In-hospital complications in patients with ST-elevation myocardial infarction receiving timely, delayed, and late pPCI compared to P-I strategy, Norway 2013-2019
| . | Timely pPCI (≤120 min) . | Delayed pPCI (121–180 min) . | Late pPCI (>180 min) . | P-I strategy . |
|---|---|---|---|---|
| n = 7238 . | n = 1537 . | n = 1012 . | n = 2338 . | |
| n . | n . | n . | n . | |
| Recurrent myocardial infarction, n (%) | 74 (1.0) | 16 (1.0) | 5 (0.5) | 11 (0.9) |
| Stroke, n (%) | 10 (0.1) | 6 (0.4) | 4 (0.4) | 18 (0.8) |
| Major bleeding, n (%) | 78 (1.1) | 21 (1.4) | 12 (1.2) | 57 (2.4) |
| Atrial fibrillation (new), n (%) | 233 (3.2) | 68 (4.4) | 44 (4.4) | 83 (3.6) |
| Ventricular tachycardia/fibrillation, n (%) | 408 (5.6) | 89 (5.8) | 60 (5.9) | 99 (4.2) |
| Cardiogenic shock, n (%) | 280 (3.9) | 99 (6.4) | 66 (6.5) | 129 (5.5) |
| In-hospital death, n (%) | 239 (3.3) | 99 (6.4) | 68 (6.7) | 93 (4.0) |
| . | Timely pPCI (≤120 min) . | Delayed pPCI (121–180 min) . | Late pPCI (>180 min) . | P-I strategy . |
|---|---|---|---|---|
| n = 7238 . | n = 1537 . | n = 1012 . | n = 2338 . | |
| n . | n . | n . | n . | |
| Recurrent myocardial infarction, n (%) | 74 (1.0) | 16 (1.0) | 5 (0.5) | 11 (0.9) |
| Stroke, n (%) | 10 (0.1) | 6 (0.4) | 4 (0.4) | 18 (0.8) |
| Major bleeding, n (%) | 78 (1.1) | 21 (1.4) | 12 (1.2) | 57 (2.4) |
| Atrial fibrillation (new), n (%) | 233 (3.2) | 68 (4.4) | 44 (4.4) | 83 (3.6) |
| Ventricular tachycardia/fibrillation, n (%) | 408 (5.6) | 89 (5.8) | 60 (5.9) | 99 (4.2) |
| Cardiogenic shock, n (%) | 280 (3.9) | 99 (6.4) | 66 (6.5) | 129 (5.5) |
| In-hospital death, n (%) | 239 (3.3) | 99 (6.4) | 68 (6.7) | 93 (4.0) |
P-I strategy, pharmaco-invasive strategy; pPCI, primary percutaneous coronary intervention.
In-hospital complications in patients with ST-elevation myocardial infarction receiving timely, delayed, and late pPCI compared to P-I strategy, Norway 2013-2019
| . | Timely pPCI (≤120 min) . | Delayed pPCI (121–180 min) . | Late pPCI (>180 min) . | P-I strategy . |
|---|---|---|---|---|
| n = 7238 . | n = 1537 . | n = 1012 . | n = 2338 . | |
| n . | n . | n . | n . | |
| Recurrent myocardial infarction, n (%) | 74 (1.0) | 16 (1.0) | 5 (0.5) | 11 (0.9) |
| Stroke, n (%) | 10 (0.1) | 6 (0.4) | 4 (0.4) | 18 (0.8) |
| Major bleeding, n (%) | 78 (1.1) | 21 (1.4) | 12 (1.2) | 57 (2.4) |
| Atrial fibrillation (new), n (%) | 233 (3.2) | 68 (4.4) | 44 (4.4) | 83 (3.6) |
| Ventricular tachycardia/fibrillation, n (%) | 408 (5.6) | 89 (5.8) | 60 (5.9) | 99 (4.2) |
| Cardiogenic shock, n (%) | 280 (3.9) | 99 (6.4) | 66 (6.5) | 129 (5.5) |
| In-hospital death, n (%) | 239 (3.3) | 99 (6.4) | 68 (6.7) | 93 (4.0) |
| . | Timely pPCI (≤120 min) . | Delayed pPCI (121–180 min) . | Late pPCI (>180 min) . | P-I strategy . |
|---|---|---|---|---|
| n = 7238 . | n = 1537 . | n = 1012 . | n = 2338 . | |
| n . | n . | n . | n . | |
| Recurrent myocardial infarction, n (%) | 74 (1.0) | 16 (1.0) | 5 (0.5) | 11 (0.9) |
| Stroke, n (%) | 10 (0.1) | 6 (0.4) | 4 (0.4) | 18 (0.8) |
| Major bleeding, n (%) | 78 (1.1) | 21 (1.4) | 12 (1.2) | 57 (2.4) |
| Atrial fibrillation (new), n (%) | 233 (3.2) | 68 (4.4) | 44 (4.4) | 83 (3.6) |
| Ventricular tachycardia/fibrillation, n (%) | 408 (5.6) | 89 (5.8) | 60 (5.9) | 99 (4.2) |
| Cardiogenic shock, n (%) | 280 (3.9) | 99 (6.4) | 66 (6.5) | 129 (5.5) |
| In-hospital death, n (%) | 239 (3.3) | 99 (6.4) | 68 (6.7) | 93 (4.0) |
P-I strategy, pharmaco-invasive strategy; pPCI, primary percutaneous coronary intervention.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
